| Literature DB >> 33307416 |
Silvia Scoccianti1, Marco Perna2, Emanuela Olmetto2, Camilla Delli Paoli2, Francesca Terziani2, Lucia Pia Ciccone2, Beatrice Detti2, Daniela Greto2, Gabriele Simontacchi2, Roberta Grassi2, Erika Scoccimarro2, Pierluigi Bonomo2, Monica Mangoni2, Isacco Desideri2, Vanessa Di Cataldo2, Marco Vernaleone2, Marta Casati3, Stefania Pallotta3, Lorenzo Livi2.
Abstract
In case of circumscribed recurrent glioblastoma (rec-GBM), a second surgery (Re-S) and reirradiation (Re-RT) are local strategies to consider. The aim is to provide an algorithm to use in the daily clinical practice. The first step is to consider the life expectancy in order to establish whether the patient should be a candidate for active treatment. In case of a relatively good life expectancy (>3 months) and a confirmed circumscribed disease(i.e. without multiple lesions that are in different lobes/hemispheres), the next step is the assessment of the prognostic factors for local treatments. Based on the existing prognostic score systems, patients who should be excluded from local treatments may be identified; based on the validated prognostic factors, one or the other local treatment may be preferred. The last point is the estimation of expected toxicity, considering patient-related, tumor-related and treatment-related factors impacting on side effects. Lastly, patients with very good prognostic factors may be considered for receiving a combined treatment.Entities:
Keywords: Decision-making tree; Recurrent glioblastoma; Reirradiation; Repeat radiotherapy; Repeat surgery; Salvage treatment; Second surgery
Year: 2020 PMID: 33307416 DOI: 10.1016/j.critrevonc.2020.103184
Source DB: PubMed Journal: Crit Rev Oncol Hematol ISSN: 1040-8428 Impact factor: 6.312